Clinical Trial Update: Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis [Phase 3]

View source ↗

Summary

Open-label safety study of Tradipitant in idiopathic and diabetic gastroparesis is currently recruiting in Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis
• Gastroparesis
• Idiopathic Gastroparesis

Drugs mentioned

• Tradipitant (tradipitant)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Idiopathic Gastroparesis, Diabetic Gastroparesis | Phase 3 | Status: RECRUITING